News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Updates in the Management of Graft-Versus-Host Disease

EP. 1: Timing of Referral for Transplant

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 2: Members of the Transplant Team

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 3: Overview of Graft-Vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 4: Risk Factors for Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 5: Special Transplant Situations

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 6: Graft-vs-Host Disease Prophylaxis Clinical Trials

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 7: Shifting Paradigm in Treating Acute Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 8: Treating Chronic Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL